Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-08 Sale |
2024-04-08 9:25 pm |
Societal CDMO Inc. | SCTL | Ashton William Director |
73,620 | $1.1 | $80,982 | 0 (Direct) |
View |
| 2023-08-28 Purchase |
2023-08-28 4:33 pm |
Societal CDMO Inc. | SCTL | Ashton William Director |
22,222 | $0.455 | $10,111 | 263,622 (Direct) |
View |
| 2023-07-31 Sale |
2023-08-01 5:13 pm |
SPECTRUM PHARMACEUTICALS INC | SPPI | Ashton William Director |
67,660 | $0 | $0 | 0 (Direct) |
View |
| 2022-06-21 Sale |
2022-06-22 9:20 pm |
SPECTRUM PHARMACEUTICALS INC | SPPI | Ashton William Director |
4,283 | $0.785 | $3,362 | 42,660 (Direct) |
View |
| 2021-06-18 Sale |
2021-06-22 4:51 pm |
SPECTRUM PHARMACEUTICALS INC | SPPI | Ashton William Director |
9,000 | $4.24 | $38,160 | 114,747 (Direct) |
View |
| 2020-06-22 Sale |
2020-06-23 4:30 pm |
SPECTRUM PHARMACEUTICALS INC | SPPI | Ashton William Director |
5,000 | $3.25 | $16,250 | 101,666 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2025-01-23 6:14 pm |
N/A 2029-12-17 |
Medicus Pharma Ltd. | MDCX | Ashton William Director |
0 | $0 | 15,000 (Direct) |
View |
Ownership |
2024-12-31 4:01 pm |
N/A N/A |
Medicus Pharma Ltd. | MDCX | Ashton William Director |
0 | $0 | 26,250 (Direct) |
View |
| 2024-04-08 Equity Swap |
2024-04-08 9:25 pm |
N/A N/A |
Societal CDMO Inc. | SCTL | Ashton William Director |
190,002 | $1.1 | 0 (Direct) |
View |
| 2023-05-17 Option Award |
2023-05-19 4:56 pm |
N/A 2033-05-17 |
Societal CDMO Inc. | SCTL | Ashton William Director |
100,849 | $0 | 268,629 (Direct) |
View |
| 2022-08-31 Option Award |
2022-09-02 4:00 pm |
N/A 2032-08-31 |
SPECTRUM PHARMACEUTICALS INC | SPPI | Ashton William Director |
100,000 | $0 | 142,660 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 4:13 pm |
N/A N/A |
Baudax Bio Inc. | BXRX | Ashton William Director |
39,473 | $0 | 42,534 (Direct) |
View |
| 2022-05-18 Option Award |
2022-05-20 5:37 pm |
N/A 2032-05-18 |
Societal CDMO Inc. | SCTL | Ashton William Director |
205,682 | $0 | 285,962 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-22 4:51 pm |
N/A 2031-06-17 |
SPECTRUM PHARMACEUTICALS INC | SPPI | Ashton William Director |
82,081 | $0 | 114,747 (Direct) |
View |
| 2021-04-20 Option Award(A) |
2021-05-17 4:07 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Ashton William Director |
38,012 | $0 | 38,012 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 5:55 pm |
N/A 2031-04-20 |
Recro Pharma Inc. | REPH | Ashton William Director |
64,935 | $0 | 118,292 (Direct) |
View |
| 2021-04-07 Option Award |
2021-04-08 7:04 pm |
N/A 2031-04-07 |
Baudax Bio Inc. | BXRX | Ashton William Director |
139,785 | $0 | 190,518 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-23 4:30 pm |
N/A 2030-06-18 |
SPECTRUM PHARMACEUTICALS INC | SPPI | Ashton William Director |
60,000 | $0 | 101,666 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 4:48 pm |
N/A 2030-06-18 |
SPECTRUM PHARMACEUTICALS INC | SPPI | Ashton William Director |
90,000 | $0 | 106,666 (Direct) |
View |
| 2020-05-07 Option Award |
2020-05-11 5:04 pm |
N/A 2030-05-07 |
Recro Pharma Inc. | REPH | Ashton William Director |
20,768 | $0 | 65,762 (Direct) |
View |
| 2020-05-06 Option Award |
2020-05-08 8:19 pm |
N/A 2030-05-06 |
Baudax Bio Inc. | BXRX | Ashton William Director |
57,525 | $0 | 85,307 (Direct) |
View |